Solid Biosciences

Developer of gene therapy platform for Duchenne muscular dystrophy

placeCambridge, Massachusetts, United States calendar_todayFounded 2014 groups101 employees language solidbio.com

Registered entities

Innovation

17 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 348 times.

YearFilings
20191
20202
20215
20226
20233
20246
20259
20261

Investor mix

20 investors on record; lead investors include RA Capital Management, Bain Capital Life Sciences.

Investor typeCountShare
Venture capital945%
Private equity210%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed735%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

9 Aug 2025 · Associate Director, Quality Control · Boston

Based on job postings tracked across public sources.

Coming soon